https://www.clinicaltrialsarena.com/news/anavex-trial-schizophrenia-drug/
Anavex to commence Phase II trial of schizophrenia drug candidate
Jan 17, 2024 - Anavex Life Sciences has reported the upcoming commencement of a Phase II trial of ANAVEX 3-71 aimed at treating schizophrenia.
phase iianavexcommencetrialschizophrenia
https://public.com/stocks/avxl/options-chain?expiration=2027-01-15
Buy Anavex Life Sciences (AVXL) Call and Put Options - Options Chain
life sciencesoptions chainbuyanavexavxl
https://markets.businessinsider.com/news/stocks/anavex-life-sciences-presents-new-data-from-its-ad-004-phase-iib-iii-trial-at-ad-pd-2026-conference-demonstrating-consistent-correlation-between-the-treatment-effect-of-oral-blarcamesine-and-1035953897
Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference...
New data show brain-volume preservation correlates with patient outcomesLong-term clinical data indicate 77.4 weeks (17.8 months) time saved with ...
life sciencesnew dataanavexpresentsad
https://www.sofi.com/invest/stock/AVXL/
Buy Anavex Life Sciences Stock - AVXL Stock Price, Quote & News | SoFi
See real time price charts for AVXL stock, historical data, and recent news. Buy AVXL stock online with no commission fees.
life sciencesprice quotebuyanavexstock